🔗 Visit the ClinicalTrials.gov page for NCT00019682
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. | N Engl J Med | 2011 | 5.15 |
| 2 | Combination cancer immunotherapies tailored to the tumour microenvironment. | Nat Rev Clin Oncol | 2015 | 1.54 |
| 3 | Antigen-specific vaccines for cancer treatment. | Hum Vaccin Immunother | 2014 | 0.89 |
| 4 | Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities. | Front Immunol | 2012 | 0.80 |
| 5 | Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. | J Int AIDS Soc | 2015 | 0.78 |
| 6 | Therapeutic cancer vaccines and combination immunotherapies involving vaccination. | Immunotargets Ther | 2014 | 0.75 |